Craft

Advanced
  • Home
  •  / TAO Synergies
TAO Synergies

TAO Synergies

Stock Price

$3.2

2024-10-29

Market Capitalization

$4.3 M

2024-10-29

Revenue

$299.1 K

FY, 2025

TAO Synergies Summary

Company Summary

Overview
TAO Synergies (formerly known as Synaptogenix and Neurotrope Bioscience) is a company that engages in digital asset treasury strategy. It focuses on decentralized AI cryptocurrency.
Type
Public
Status
Active
Founded
2012
HQ
New York, NY, US | view all locations
Website
https://www.taosynergies.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Alan Tuchman

    Alan Tuchman, Chief Executive Officer

    • Daniel Alkon

      Daniel Alkon, President & Chief Science Officer

    • Robert Weinstein

      Robert Weinstein, Chief Financial Officer

    • Elaine Grenier

      Elaine Grenier, Executive Director, Clinical Ops

      LocationsView all

      2 locations detected

      • New York, NY HQ

        United States

        1185 6th Avenue of the Americas, Suite 249

      • Sarasota, FL

        United States

        1343 Main St UNIT 411

      TAO Synergies Financials

      Summary Financials

      Revenue (Q1, 2026)
      $388.8K
      Gross profit (Q1, 2026)
      $371.4K
      Net income (Q1, 2026)
      $4.3M
      Cash (Q1, 2026)
      $3.6M
      EBIT (Q1, 2026)
      ($1.3M)

      Competitors and Similar Companies

      Compare competitors

      Footer menu

      Product

      Solutions

      Resources

      Company

      © Craft.co 2026
      Share price data provided by IEX